CorpStrat
APRIL 30, 2025
But heres the hidden truth: tariffs may quietly drive up the cost of employer-sponsored health benefits, affecting your bottom line and your ability to attract and retain talent. When tariffs are imposed on foreign goods (especially from major suppliers like China, India, or the EU), the cost of these essentials increases.
InterWest Insurance Services
AUGUST 15, 2024
As prescription drug costs continue growing and pricey new pharmaceuticals add to health plans’ cost burdens, some carriers are starting to reduce the number of medications they’ll cover and are imposing new barriers to accessing the most expensive ones. On top of it all, pharmaceuticals are getting more expensive.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Higginbotham
APRIL 8, 2025
The decisions can have a ripple effect into other areas, such as: Increased Health Insurance Costs: Premium increases directly impact the budget and total health spending that is dedicated to employee benefit programs and services. Evaluate pharmacy benefit management strategies for cost efficiency.
McDermott Will & Emery Employee Benefits
OCTOBER 17, 2023
Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government. Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. appeared first on EMPLOYEE BENEFITS BLOG.
Griffin Benefits
MARCH 9, 2022
Because of its increased percentage of total drug spending, specialty drug costs are proving a major headache for plan sponsors. They need to find ways to control spending on these treatments, lest the cost of the drug benefit become prohibitive. Here are three ways to manage the cost of pharmaceutical benefits.
InterWest Insurance Services
JUNE 22, 2023
The changes mean some or many of your employees will see significant reductions in their pharmaceutical outlays, particularly if they have high copays or deductibles. The moves come after the Inflation Reduction Act, signed into law in 2022, capped out-of-pocket insulin costs for seniors on Medicare at $35 per month.
Griffin Benefits
JULY 30, 2021
And while consumers seem to have a love/hate relationship with HDHPs, many of those who take the time to fully calculate the total out-of-pocket cost of medical coverage and care realize that HDHPs, even with higher deductibles, can often save them money. Pharmaceutical Company & State Drug Assistance Programs.
Expert insights. Personalized for you.
52 
Let's personalize your content